Search research articles
Contact Us
Filters
Showing results (11-20 of 54) with videos related to
Page
of 6
Sort By:
Cell
|
October 4, 2011
A DNA repair complex functions as an Oct4/Sox2 coactivator in embryonic stem cells
Yick W Fong, Carla Inouye, Teppei Yamaguchi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 16, 2018
Pre-existing pulmonary fibrosis is a risk factor for anti-PD-1-related pneumonitis in patients with non-small cell lung cancer: A retrospective analysis
Teppei Yamaguchi, Junichi Shimizu, Takaaki Hasegawa, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 15, 2016
Short hydration regimen with magnesium supplementation prevents cisplatin-induced nephrotoxicity in lung cancer: a retrospective analysis
Teppei Yamaguchi, Sakurako Uozu, Sumito Isogai, et al.
Genes & Development
|
March 3, 2010
Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression
Teppei Yamaguchi, Fabien Cubizolles, Yu Zhang, et al.
Thoracic Cancer
|
January 19, 2022
Risk factors for pneumonitis in patients with non-small cell lung cancer treated with immune checkpoint inhibitors plus chemotherapy: A retrospective analysis
Teppei Yamaguchi, Junichi Shimizu, Yuko Oya, et al.
Frontiers in Oncology
|
June 26, 2024
The incidence of drug-induced interstitial lung disease caused by epidermal growth factor receptor tyrosine kinase inhibitors or immune checkpoint inhibitors in patients with non-small cell lung cancer in presence and absence of vascular endothelial growth factor inhibitors: a systematic review
Yutaka Fujiwara, Kazuhiro Shimomura, Teppei Yamaguchi, et al.
Journal of Thoracic Disease
|
June 17, 2024
Atezolizumab and nintedanib in patients with non-small cell lung cancer and interstitial lung disease
Teppei Yamaguchi, Junichi Shimizu, Fumie Shigematsu, et al.
BMC Cancer
|
August 17, 2021
Pre-existing interstitial lung disease is associated with onset of nivolumab-induced pneumonitis in patients with solid tumors: a retrospective analysis
Teppei Yamaguchi, Junichi Shimizu, Takaaki Hasegawa, et al.
Case Reports in Oncology
|
October 30, 2024
Long-Term Response of Lorlatinib to Leptomeningeal Metastasis in Patients with Anaplastic Lymphoma Kinase Fusion Positive Non-Small Lung Cancer: A Case Report
Yutaka Fujiwara, Katsuhiro Masago, Reiko Matsuzawa, et al.
Scientific Reports
|
November 26, 2016
Histone deacetylase 1 plays a predominant pro-oncogenic role in Eμ-myc driven B cell lymphoma
Vincent Pillonel, Nina Reichert, Chun Cao, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 54) with videos related to
Sort By:
Page
of 6
Cell
|
October 4, 2011
A DNA repair complex functions as an Oct4/Sox2 coactivator in embryonic stem cells
Yick W Fong, Carla Inouye, Teppei Yamaguchi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 16, 2018
Pre-existing pulmonary fibrosis is a risk factor for anti-PD-1-related pneumonitis in patients with non-small cell lung cancer: A retrospective analysis
Teppei Yamaguchi, Junichi Shimizu, Takaaki Hasegawa, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 15, 2016
Short hydration regimen with magnesium supplementation prevents cisplatin-induced nephrotoxicity in lung cancer: a retrospective analysis
Teppei Yamaguchi, Sakurako Uozu, Sumito Isogai, et al.
Genes & Development
|
March 3, 2010
Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression
Teppei Yamaguchi, Fabien Cubizolles, Yu Zhang, et al.
Thoracic Cancer
|
January 19, 2022
Risk factors for pneumonitis in patients with non-small cell lung cancer treated with immune checkpoint inhibitors plus chemotherapy: A retrospective analysis
Teppei Yamaguchi, Junichi Shimizu, Yuko Oya, et al.
Frontiers in Oncology
|
June 26, 2024
The incidence of drug-induced interstitial lung disease caused by epidermal growth factor receptor tyrosine kinase inhibitors or immune checkpoint inhibitors in patients with non-small cell lung cancer in presence and absence of vascular endothelial growth factor inhibitors: a systematic review
Yutaka Fujiwara, Kazuhiro Shimomura, Teppei Yamaguchi, et al.
Journal of Thoracic Disease
|
June 17, 2024
Atezolizumab and nintedanib in patients with non-small cell lung cancer and interstitial lung disease
Teppei Yamaguchi, Junichi Shimizu, Fumie Shigematsu, et al.
BMC Cancer
|
August 17, 2021
Pre-existing interstitial lung disease is associated with onset of nivolumab-induced pneumonitis in patients with solid tumors: a retrospective analysis
Teppei Yamaguchi, Junichi Shimizu, Takaaki Hasegawa, et al.
Case Reports in Oncology
|
October 30, 2024
Long-Term Response of Lorlatinib to Leptomeningeal Metastasis in Patients with Anaplastic Lymphoma Kinase Fusion Positive Non-Small Lung Cancer: A Case Report
Yutaka Fujiwara, Katsuhiro Masago, Reiko Matsuzawa, et al.
Scientific Reports
|
November 26, 2016
Histone deacetylase 1 plays a predominant pro-oncogenic role in Eμ-myc driven B cell lymphoma
Vincent Pillonel, Nina Reichert, Chun Cao, et al.
Page
of 6